EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evaluation of Prostate-Specific Membrane Antigen (PSMA) Immunohistochemical Expression in Early-Stage Breast Cancer Subtypes

Natalia Andryszak iD, Paweł Kurzawa, Monika Krzyżaniak, Michał Nowicki iD, Marek Ruchała iD, Dariusz Iżycki, Rafał Czepczyński iD

International Journal of Molecular Sciences · 13.06.2024 · 25 (12) · 6519

DOI: 10.3390/ijms25126519 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 13.06.2024. Verfasst von Natalia Andryszak und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Metabolism and Internal Medicine, Poznan University of Medical Sciences, 60-355 Poznan, Poland. Hauptthemen laut MEDLINE: Breast Neoplasms, Glutamate Carboxypeptidase II, Antigens, Surface, Biomarkers, Tumor. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Higher Education of the Republic of Poland.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer, known for its diverse subtypes, ranks as one of the leading causes of cancer-related deaths. Prostate-specific membrane antigen (PSMA), primarily associated with prostate cancer, has also been identified in breast cancer, though its role remains unclear. This study aimed to evaluate PSMA expression across different subtypes of early-stage breast cancer and investigate its correlation with clinicopathological factors. This retrospective study included 98 breast cancer cases. PSMA expression was examined in both tumor cells and tumor-associated blood vessels. The analysis revealed PSMA expression in tumor-associated blood vessels in 88 cases and in tumor cells in 75 cases. Ki67 expression correlated positively with PSMA expression in blood vessels (p < 0.0001, RSpearman 0.42) and tumor cells (p = 0.010, RSpearman 0.26). The estrogen and progesterone receptor expression correlated negatively with PSMA levels in blood vessels (p = 0.0053, R Spearman −0.26 and p = 0.00026, R Spearman −0.347, respectively). Human epidermal growth factor receptor 2 (HER2) status did not significantly impact PSMA expression. We did not detect any statistically significant differences between breast cancer subtypes. These findings provide evidence for a heterogenous PSMA expression in breast cancer tissue and suggest its correlation with tumor aggressiveness. Despite the limited sample size, the study provides valuable insights into the potential of PSMA as a prognostic, diagnostic, and therapeutic target in the management of breast cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsGlutamate Carboxypeptidase IIAntigens, SurfaceBiomarkers, TumorImmunohistochemistryHumansFemaleMiddle AgedAgedRetrospective StudiesNeoplasm StagingAdultErb-b2 Receptor Tyrosine KinasesReceptors, EstrogenReceptors, ProgesteroneAged, 80 and over

Stichwörter der Autor:innen

PSMAbreast cancerprostate-specific membrane antigen

Substanzen

Glutamate Carboxypeptidase IIAntigens, SurfaceBiomarkers, TumorErb-b2 Receptor Tyrosine KinasesReceptors, EstrogenReceptors, ProgesteroneFOLH1 protein, humanERBB2 protein, human

Autor:innen und Institutionen

  • Department of Endocrinology, Metabolism and Internal Medicine, Poznan University of Medical Sciences, 60-355 Poznan, Poland.
  • Department of Oncological Pathology, Hospital of Lord's Transfiguration, Poznan University of Medical Sciences, 60-101 Poznan, Poland.
  • Department of Histology and Embryology, Poznan University of Medical Sciences, 60-781 Poznan, Poland.
  • Department of Cancer Immunology, Poznan University of Medical Sciences, 60-101 Poznan, Poland.

ORCID-Profile: Natalia Andryszak, Michał Nowicki, Marek Ruchała, Rafał Czepczyński

Förderung

  • Ministry of Science and Higher Education of the Republic of Poland

Zitieren

APA

Andryszak, N., Kurzawa, P., Krzyżaniak, M., Nowicki, M., Ruchała, M., Iżycki, D., & Czepczyński, R. (2024). Evaluation of Prostate-Specific Membrane Antigen (PSMA) Immunohistochemical Expression in Early-Stage Breast Cancer Subtypes. International Journal of Molecular Sciences, 25(12), 6519. https://doi.org/10.3390/ijms25126519

Vancouver

Andryszak N, Kurzawa P, Krzyżaniak M, Nowicki M, Ruchała M, Iżycki D, et al. Evaluation of Prostate-Specific Membrane Antigen (PSMA) Immunohistochemical Expression in Early-Stage Breast Cancer Subtypes. International Journal of Molecular Sciences. 2024;25(12):6519. doi:10.3390/ijms25126519

BibTeX
@article{Andryszak2024,
  author = {Andryszak, Natalia and Kurzawa, Paweł and Krzyżaniak, Monika and Nowicki, Michał and Ruchała, Marek and Iżycki, Dariusz and Czepczyński, Rafał},
  title = {Evaluation of Prostate-Specific Membrane Antigen (PSMA) Immunohistochemical Expression in Early-Stage Breast Cancer Subtypes},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {12},
  pages = {6519},
  doi = {10.3390/ijms25126519}
}
Kostenlos starten →